Adhera Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adhera Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • Adhera Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -5.81K %, a 574% decline year-over-year.
  • Adhera Therapeutics, Inc. annual Return On Assets for 2022 was -571 %, a 91.2% increase from 2021.
  • Adhera Therapeutics, Inc. annual Return On Assets for 2021 was -6.51K %, a 126% decline from 2020.
  • Adhera Therapeutics, Inc. annual Return On Assets for 2020 was -2.89K %, a 537% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -5.81K -4.95K -574% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.12K -673 -46.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -827 +3.46K +80.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -571 +5.94K +91.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -863 +9.73K +91.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.44K +6.57K +82% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.29K +240 +5.29% Jan 1, 2022 Mar 31, 2022
Q4 2021 -6.51K -3.63K -126% Oct 1, 2021 Dec 31, 2021
Q3 2021 -10.6K -7.46K -238% Jul 1, 2021 Sep 30, 2021
Q2 2021 -8.02K -7.27K -973% Apr 1, 2021 Jun 30, 2021
Q1 2021 -4.53K -3.94K -667% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.89K -2.43K -537% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.13K -2.85K -1003% Jul 1, 2020 Sep 30, 2020
Q2 2020 -747 -417 -126% Apr 1, 2020 Jun 30, 2020
Q1 2020 -590 -360 -156% Jan 1, 2020 Mar 31, 2020
Q4 2019 -453 -256 -130% Oct 1, 2019 Dec 31, 2019
Q3 2019 -284 -92.3 -48.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -331 -210 -173% Apr 1, 2019 Jun 30, 2019
Q1 2019 -230 -127 -123% Jan 1, 2019 Mar 31, 2019
Q4 2018 -197 -98.4 -99.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -192 -133 -224% Jul 1, 2018 Sep 30, 2018
Q2 2018 -121 -76.9 -174% Apr 1, 2018 Jun 30, 2018
Q1 2018 -103 -75.9 -277% Jan 1, 2018 Mar 31, 2018
Q4 2017 -98.8 -86.6 -708% Oct 1, 2017 Dec 31, 2017
Q3 2017 -59.1 +19.7 +25% Jul 1, 2017 Sep 30, 2017
Q2 2017 -44.1 +2.91 +6.19% Apr 1, 2017 Jun 30, 2017
Q1 2017 -27.4 +0.89 +3.14% Jan 1, 2017 Mar 31, 2017
Q4 2016 -12.2 +6.26 +33.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -78.8 -183 -176% Jul 1, 2016 Sep 30, 2016
Q2 2016 -47 -47 -204347% Apr 1, 2016 Jun 30, 2016
Q1 2016 -28.3 -59.8 -190% Jan 1, 2016 Mar 31, 2016
Q4 2015 -18.5 +42.3 +69.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 104 +243 Jul 1, 2015 Sep 30, 2015
Q2 2015 -0.02 +84.4 +100% Apr 1, 2015 Jun 30, 2015
Q1 2015 31.5 +172 Jan 1, 2015 Mar 31, 2015
Q4 2014 -60.8 -38.9 -177% Oct 1, 2014 Dec 31, 2014
Q3 2014 -138 -86.8 -168% Jul 1, 2014 Sep 30, 2014
Q2 2014 -84.4 -23.7 -39.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -141 -99.8 -243% Jan 1, 2014 Mar 31, 2014
Q4 2013 -21.9 +83.2 +79.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -51.6 +178 +77.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -60.7 +110 +64.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -41.1 +107 +72.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -105 Oct 1, 2012 Dec 31, 2012
Q3 2012 -229 Jul 1, 2012 Sep 30, 2012
Q2 2012 -171 Mar 31, 2012 Jun 30, 2012
Q1 2012 -148 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.